Curanex Pharmaceuticals, Inc. (CURX)
0.4453
0.00 (0.00%)
USD |
NASDAQ |
Dec 04, 16:00
0.4499
0.00 (0.00%)
After-Hours: 20:00
Curanex Pharmaceuticals Total Assets (Quarterly): 14.48M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp. | 20.34M |
| AIM ImmunoTech, Inc. | 5.494M |
| IGC Pharma, Inc. | 9.743M |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
| Protalix Biotherapeutics, Inc. | 82.26M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.186M |
| Shareholders Equity (Quarterly) | 14.29M |
| Debt to Equity Ratio | 0.0043 |
| Current Ratio | 77.52 |
| Net Debt Paydown Yield | -0.06% |